These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 21787230)
1. Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells. Kim SY; Kim MJ; Jung H; Kim WK; Kwon SO; Son MJ; Jang IS; Choi JS; Park SG; Park BC; Han YM; Lee SC; Cho YS; Bae KH Stem Cells Dev; 2012 May; 21(8):1272-86. PubMed ID: 21787230 [TBL] [Abstract][Full Text] [Related]
2. Combining membrane proteomics and computational three-way pathway analysis revealed signalling pathways preferentially regulated in human iPSCs and human ESCs. Tien WS; Chen PM; Chuang CY; Lui SM; Kuo HC; Chen YJ; Wu KP Sci Rep; 2017 Nov; 7(1):15055. PubMed ID: 29118436 [TBL] [Abstract][Full Text] [Related]
3. An orthogonal comparison of the proteome of human embryonic stem cells with that of human induced pluripotent stem cells of different genetic background. Faradonbeh MZ; Gharechahi J; Mollamohammadi S; Pakzad M; Taei A; Rassouli H; Baharvand H; Salekdeh GH Mol Biosyst; 2012 Jun; 8(6):1833-40. PubMed ID: 22543856 [TBL] [Abstract][Full Text] [Related]
4. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells. Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells. Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862 [TBL] [Abstract][Full Text] [Related]
7. Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers. Tao Y; Zheng W; Jiang Y; Ding G; Hou X; Tang Y; Li Y; Gao S; Chang G; Zhang X; Liu W; Kou X; Wang H; Jiang C; Gao S BMC Biol; 2014 Dec; 12():109. PubMed ID: 25528259 [TBL] [Abstract][Full Text] [Related]
8. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. Ghosh Z; Wilson KD; Wu Y; Hu S; Quertermous T; Wu JC PLoS One; 2010 Feb; 5(2):e8975. PubMed ID: 20126639 [TBL] [Abstract][Full Text] [Related]
9. Reprogramming- and pluripotency-associated membrane proteins in mouse stem cells revealed by label-free quantitative proteomics. Hao J; Li W; Dan J; Ye X; Wang F; Zeng X; Wang L; Wang H; Cheng Y; Liu L; Shui W J Proteomics; 2013 Jun; 86():70-84. PubMed ID: 23615220 [TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomics of protein complexes and their implications for cell reprograming and pluripotency. Sudhir PR; Kumari MP; Hsu WT; Massiot J; Chen CH; Kuo HC; Chen CH J Proteome Res; 2013 Dec; 12(12):5878-90. PubMed ID: 24256468 [TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310 [TBL] [Abstract][Full Text] [Related]
12. Human and mouse induced pluripotent stem cells are differentially reprogrammed in response to kinase inhibitors. Hirano K; Nagata S; Yamaguchi S; Nakagawa M; Okita K; Kotera H; Ainscough J; Tada T Stem Cells Dev; 2012 May; 21(8):1287-98. PubMed ID: 21882976 [TBL] [Abstract][Full Text] [Related]
13. Genetically unmatched human iPSC and ESC exhibit equivalent gene expression and neuronal differentiation potential. Marei HE; Althani A; Lashen S; Cenciarelli C; Hasan A Sci Rep; 2017 Dec; 7(1):17504. PubMed ID: 29235536 [TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells. Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219 [TBL] [Abstract][Full Text] [Related]
15. TaqMan® OpenArray® high-throughput transcriptional analysis of human embryonic and induced pluripotent stem cells. Patel SN; Wu Y; Bao Y; Mancebo R; Au-Young J; Grigorenko E Methods Mol Biol; 2013; 997():191-201. PubMed ID: 23546757 [TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation. Jozefczuk J; Prigione A; Chavez L; Adjaye J Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674 [TBL] [Abstract][Full Text] [Related]
17. Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis. Pripuzova NS; Getie-Kebtie M; Grunseich C; Sweeney C; Malech H; Alterman MA Stem Cell Res; 2015 May; 14(3):323-38. PubMed ID: 25840413 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation dynamics in human induced pluripotent stem cells. Nishino K; Umezawa A Hum Cell; 2016 Jul; 29(3):97-100. PubMed ID: 27083573 [TBL] [Abstract][Full Text] [Related]
19. Proteomic Analysis of Mouse Oocytes Identifies PRMT7 as a Reprogramming Factor that Replaces SOX2 in the Induction of Pluripotent Stem Cells. Wang B; Pfeiffer MJ; Drexler HC; Fuellen G; Boiani M J Proteome Res; 2016 Aug; 15(8):2407-21. PubMed ID: 27225728 [TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic analysis of mouse embryonic fibroblasts and induced pluripotent stem cells using 16O/18O labeling. Huang X; Tian C; Liu M; Wang Y; Tolmachev AV; Sharma S; Yu F; Fu K; Zheng J; Ding SJ J Proteome Res; 2012 Apr; 11(4):2091-102. PubMed ID: 22375802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]